Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Inventory Average (2019 - 2025)

Akebia Therapeutics (AKBA) has disclosed Inventory Average for 7 consecutive years, with $17.1 million as the latest value for Q4 2025.

  • Quarterly Inventory Average fell 6.76% to $17.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.1 million through Dec 2025, down 6.76% year-over-year, with the annual reading at $15.9 million for FY2025, 0.25% changed from the prior year.
  • Inventory Average for Q4 2025 was $17.1 million at Akebia Therapeutics, down from $17.7 million in the prior quarter.
  • The five-year high for Inventory Average was $52.9 million in Q1 2021, with the low at $17.1 million in Q4 2023.
  • Average Inventory Average over 5 years is $27.8 million, with a median of $21.6 million recorded in 2023.
  • The sharpest move saw Inventory Average plummeted 62.88% in 2021, then increased 19.58% in 2024.
  • Over 5 years, Inventory Average stood at $35.2 million in 2021, then fell by 4.99% to $33.4 million in 2022, then tumbled by 48.91% to $17.1 million in 2023, then increased by 7.63% to $18.4 million in 2024, then dropped by 6.76% to $17.1 million in 2025.
  • According to Business Quant data, Inventory Average over the past three periods came in at $17.1 million, $17.7 million, and $18.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.